RadNet, Inc. (RDNT) Q1 2026 Earnings Call Transcript – Image for illustrative purposes only (Image credits: Pexels)
RadNet delivered a solid start to 2026 with revenue growth that outpaced expectations and prompted the company to raise its full-year financial targets. The outpatient imaging provider reported total revenue of $575.6 million for the quarter ended March 31, a 22.1 percent increase from the same period a year earlier. Adjusted EBITDA rose even faster at 36.3 percent to $63.3 million, reflecting operational leverage even as the company absorbed weather-related disruptions and continued investments in its digital health platform.
Core Imaging Operations Drive Growth
Advanced imaging volumes increased 19.7 percent systemwide, with a noticeable shift toward higher-value procedures such as PET/CT and MRI. This mix change helped lift overall margins despite a net loss of $24.73 million, or 43 cents per share, which narrowed from the prior-year loss. The improvement came as RadNet expanded its network through joint ventures and acquisitions while maintaining steady patient demand for diagnostic services across its centers. Stakeholders in the healthcare supply chain, from referring physicians to hospital partners, benefit from this scale because it supports faster turnaround times and broader geographic coverage for routine and complex scans.
Digital Health Segment Accelerates
Revenue from the digital health business jumped 51.5 percent to $29.1 million, fueled in part by the March acquisition of Gleamer and strong sales bookings. Annual recurring revenue for the segment reached $96.9 million at quarter end, nearly doubling from $49.8 million a year earlier. These recurring streams provide more predictable cash flow and position RadNet to integrate artificial intelligence tools into its imaging workflow. The segment still posted a modest adjusted EBITDA loss of $1.3 million as the company funds infrastructure to support a growing pipeline of enterprise customers.
Raised Guidance Signals Confidence
Management lifted its 2026 outlook for the imaging center segment to revenue between $2.355 billion and $2.405 billion, adjusted EBITDA of $340 million to $353 million, and free cash flow of $112 million to $122 million. Digital health guidance remained unchanged. The upward revision reflects sustained volume trends and successful integration of recent acquisitions. Investors responded positively, with shares rising in after-hours trading following the May 11 release.
What Comes Next for Patients and Providers
Continued expansion of advanced imaging capacity and AI-assisted tools should translate into earlier detection of conditions such as cancer and cardiovascular disease for the millions of patients who rely on RadNet centers each year. The company’s focus on operational efficiency also supports stable pricing and broader access in underserved markets. As RadNet executes on its updated plan, the primary watch items remain volume trends in the second half and the pace of digital health contract wins.
